105 filings
Page 3 of 6
8-K
aug9wu
19 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
12cp 7a25vhh
6 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
4eefj5ue db
30 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
8pk667nrvpxagy54wul1
6 Jan 12
Departure of Directors or Certain Officers
12:00am
8-K
cio6jz7spy
6 Dec 11
Departure of Directors or Certain Officers
12:00am
8-K
haafg alokeep2b4
9 Aug 11
Departure of Directors or Certain Officers
12:00am
8-K
28vhnu1b8me6
4 Aug 11
Departure of Directors or Certain Officers
12:00am
8-K
vtf1td5
16 Mar 11
RegeneRx Phase 2 AMI Trial on Clinical Hold due to GMP Compliance Issues at Contract Manufacturer
12:00am
8-K
41o 0fdgsf03unea
7 Jan 11
RegeneRx Biopharmaceuticals Receives $1.45 Million and Secures Additional $11 Million in Committed Funding
12:00am
8-K
y58z0o
21 Dec 10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
75pbb9
1 Nov 10
RegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request Hearing
12:00am
8-K
nxron3yv2gj1yk4
2 Sep 10
RegeneRx Appoints R. Don Elsey to Board of Directors
12:00am
8-K
39mkt fp707rt
20 Jul 10
Departure of Directors or Certain Officers
12:00am
8-K
opkn8xkm3ua h5sw3pp
14 Jul 10
Regulation FD Disclosure
12:00am
8-K
vh2vle aa
21 May 10
RegeneRx Announces Pricing of Public Offering
12:00am
8-K
prkyh2
29 Oct 09
Regulation FD Disclosure
12:00am
8-K
kwlm2nb2u3 owo
14 Oct 09
Departure of Directors or Certain Officers
12:00am
8-K
64ws5zb5lt8
5 Oct 09
Entry into a Material Definitive Agreement
12:00am
8-K/A
u7iziaw a7ni0
5 Oct 09
Financial Statements and Exhibits
12:00am
8-K
7vjsh5p fs
30 Sep 09
RegeneRx Announces Offerings of Common Stock in Aggregate Amount of $4.7 Million
12:00am